BenevolentAI Results Presentation Deck slide image

BenevolentAI Results Presentation Deck

World-class team We "build tech in the service of science" 48% Drug Discovery Bus Ops As of December 2022 15% 350+ World Class Scientists & Technologists 37% Tech Board of Industry Luminaries Combines deep expertise across Al, pharma, & drug discovery & development Baroness Joanna Shields CEO & Executive Director Jean Raby Non-Executive Director François Nader Chairman Jackie Hunter Non-Executive Director BenevolentAl Proprietary Susan Liautaud Non-Executive Director Nigel Shadbolt Non-Executive Director Olivier Brandicourt Non-Executive Director John Orloff Non-Executive Director Benevolent 26
View entire presentation